Reduced risk of post ERCP pancreatitis in statin users
Abstract Background One of the most feared complications of endoscopic retrograde cholangiopancreatography (ERCP), with an incidence of 3.5 to 15%, is post ERCP pancreatitis (PEP). Given the role of statins in the reduction of systemic and pancreatic intraluminal inflammation, we hypothesized that t...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2020-04-01
|
| Col·lecció: | BMC Gastroenterology |
| Matèries: | |
| Accés en línia: | http://link.springer.com/article/10.1186/s12876-020-01264-5 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|